One in eight men will be diagnosed with prostate cancer in his lifetime. While studies have indicated that overall cancer incidence rates among men in the U.S. Veterans Affairs Health System mirrored those of the general population, statistics now show that the incidence rate for military personnel is 1 in 5. It is important to understand your personal risk. To help Veterans impacted by this disease, ZERO has set up programming specific to Veterans and their needs. Click here to learn more.
The United States has an aging Veteran population, and your risk of developing prostate cancer increases with age. Furthermore, Veterans who were exposed to herbicides, such as Agent Orange, are also at increased risk. Talk with your healthcare team to understand your risk and make a plan for regular testing. Learn more about the statistical link between Veterans and prostate cancer by downloading this infographic.
Healthcare for Veterans
The Department of Veterans Affairs provides health benefits and services for eligible veterans who participated in active military service. Some members of the Reserves or National Guard are also eligible for VA benefits. There are several requirements you must meet for eligibility, so it is important to contact the VA directly if you think you are eligible for health services. Coverage generally includes treatments, procedures, supplies, and services. Click here to visit the VA’s website and learn more about these benefits.
For veterans who are already enrolled in VA healthcare, the MISSION Act allows you to receive healthcare within your community without impacting your existing VA healthcare or any other VA benefit. If you have been, or will be, waiting more than 20 days for VA medical care (28 days for specialty care), if you live more than a 30-minute drive from a VA primary care, mental health and extended care service facility (or a 60-minute drive for specialty care), or if you need a service not offered at any VA medical facility, you may be eligible for this program. Click here for more information on the VA MISSION Act.
Patients and providers can watch these videos about how to access care via the Mission Act.
ZERO also has helpful PDFs available for print and download that provide information on the Mission Act for both patients and physicians. Click here to print or download a PDF for patients, and here for a PDF for physicians.
Another healthcare program available for uniformed service members (active, Guard/Reserve, and retired) and their families is TRICARE. TRICARE is a major part of the Military Health System and offers an expansive provider network and services in both military and civilian healthcare facilities. Click here for more information on TRICARE.
Prostate Cancer and Agent Orange
Certain unique factors may put veterans, especially those who served in the Vietnam or Korean wars, at increased risk for developing prostate cancer. A 1996 report published by the Health and Medicine Division of the National Academy of Sciences, Engineering, and Medicine concluded that there is a link between prostate cancer and exposure to herbicides such as Agent Orange, which was used during the Vietnam and Korean wars. Similarly, a 2013 study conducted at the Portland VA Medical Center and Oregon Health and Science University found that veterans exposed to Agent Orange were at an increased risk for both developing prostate cancer and developing more aggressive forms of the disease.
Veterans with prostate cancer who were exposed to herbicides during active service may be eligible for disability compensation through the VA. There are several eligibility requirements to receive these benefits, and it is important to contact the VA directly if you think you are eligible. Click here to visit the VA’s website and learn more about these benefits and services.
Clinical Trials for Veterans
Below is information on clinical trials specific to veterans. To learn more about clinical trials, steps to find a clinical trial, and additional active clinical trials, please visit our Clinical Trials section.
- 18F-DCFPyL PET/CT Impact on Treatment Strategies for Patients With Prostate Cancer (PROSPYL) (NCT04390880)
- The main purpose of this phase II trial study is to determine whether a positron emission tomography (PET)/computed tomography (CT) scan using 18F-DCFPyL affects the clinical management plan in Veterans. In this study, the management plan prior to and after 18F-DCFPyL PET/CT will be recorded by specific questionnaires and corresponding changes in management will be analyzed. The scan will be used to see how the disease has spread. Both the treatment strategies and probable disease outcomes as relevant to clinical endpoints will be assessed. This study is open to Veterans only. Click here to learn more about this study sponsored by the VA Greater Los Angeles Healthcare System.